Pravastatin as a Prophylactic to Reduce Endothelial Injury in Pediatric Patients With Elevated Body Mass Index

Conditions:   Hematopoietic Stem Cell Transplant (HSCT);   Endothelial Injury Intervention:   Drug: Pravastatin Sponsor:   Children's Hospital Medical Center, Cincinnati Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials